The Latest Cardiac and Vascular News
NASDAQ: CORV TSX: CORV VANCOUVER, April 8, 2020 /PRNewswire/ – Correvio Pharma Corp. (“Correvio” or the “Company“) (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has obtained an interim order from the Supreme Court of British Columbia (the “Court“) authorizing the holding of an annual general and special meeting […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced preliminary financial results for the first quarter 2020 and provided updates in response to the COVID-19 pandemic. “Through these challenging times, our first priority continues to be the […]
ENGLEWOOD, Colo., April 7, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased revenue estimate for Q1 and the full year 2020. Orders in the first quarter […]
MALVERN, Pa., April 07, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that Dr. Andrei Stoica has been named Chief Technology Officer of the company. Dr. […]
by Tori Leets | Apr 6, 2020 | Ken Dropiewski, Placement Announcement McDermott + Bull has successfully placed Richard Van Bibber as the Vice President of Clinical Affairs at Adagio Medical, Inc. He will be charged with overseeing and managing the company’s sponsored global pre-market and post-market clinical studies and is currently driving the enrollment and […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that its preliminary unaudited revenue for the first quarter ended March 31, 2020 is expected to be approximately $28.5 million. Total cash, cash equivalents, and restricted cash as of March […]
WARRINGTON, Pa., April 2, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today reported financial results for the fourth quarter ended December 31, 2019 and provided key business updates. Key Business and Financial […]
FAIRWAY, Kan., March 31, 2020 /PRNewswire/ — Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular and neurovascular markets, announced today it has closed an additional $8.8 million in Series A financing, bringing the total capital raised to date to more than $20 million. “Artio is developing a strong […]
CLEVELAND, March 31, 2020 /PRNewswire/ — S4 Medical, an innovative medical device company focused on protecting the esophagus from damage during catheter ablation procedures, announced that Roy Tanaka has joined its board of directors, rounding out an impressive team. S4 Medical has developed a novel catheter called the “esolution” that utilizes a proprietary approach to […]
WARRINGTON, Pa., March 31, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, announces it has entered into a binding term sheet (the “Term Sheet”) with Lee’s Pharmaceutical Holdings (HK) Ltd (“Lee’s”) […]
